Immune checkpoint inhibitors in cancer immunotherapy

CMAJ. 2020 Jun 15;192(24):E651. doi: 10.1503/cmaj.191231.

Authors

Megan E Himmel¹, Samuel D Saibil¹, Alexandra P Saltman²

Affiliations

¹ Divisions of Rheumatology (Himmel, Saltman), Medical Oncology (Saibil) and Palliative Care (Saltman), Department of Medicine, University of Toronto, Toronto, Ont.
² Divisions of Rheumatology (Himmel, Saltman), Medical Oncology (Saibil) and Palliative Care (Saltman), Department of Medicine, University of Toronto, Toronto, Ont. Alexandra.Saltman@sinaihealthsystem.ca.

No abstract available

MeSH terms

Humans
Immune Checkpoint Inhibitors / administration & dosage
Immune Checkpoint Inhibitors / therapeutic use*
Immunotherapy
Neoplasms / drug therapy*

Substances

Immune Checkpoint Inhibitors